Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4457

Next 25
Website Changes
07/20/2017 Camp Jinka is a free summer program for kids and teens whose lives have been impacted by the diagnosis of a brain tumor .
07/19/2017 Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment
07/19/2017 The Cedars-Sinai Department of Neurosurgery Presents Outsmarting Brain Tumors: A Conference on Brain Tumors for Patients, Families and Caregivers
07/19/2017 HOW NOT TO DIE: ‘STUPID CANCER’ COMMUNITY HELPS ANGRY YOUNG PEOPLE LIVE
07/06/2017 Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
07/06/2017 Optimizing bevacizumab dosing in glioblastoma: less is more.
07/06/2017 Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
06/24/2017 No measurable gadolinium in children’s brains even after multiple doses
06/23/2017 Musella Foundation (and our copay assistance program) will be closed the week of June 25- July 3
06/21/2017 Looking Ahead: Combination Offers New Hope For Glioblastoma
06/21/2017 Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes `strategic alternatives`
06/18/2017 Diffusion Pharmaceuticals seeks Wall Street investment while staying local
06/17/2017 A Nontoxic Pill to Replace Chemotherapy? It’s Possible
06/16/2017 Researchers assess pinworm medication for adults, children with glioblastoma
06/12/2017 First Patient Enrolled in RTOG Trial of Optune® together with Bevacizumab for Patients with Bevacizumab-Refractory Recurrent Glioblastoma
06/08/2017 FDA has approved Gleolan
06/07/2017 Medicenna’s Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology
06/07/2017 Five years before brain cancer diagnosis, changes detectable in blood
06/07/2017 New Target Found to Attack an Incurable Brain Tumor in Children
06/07/2017 Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study
06/01/2017
05/30/2017 Efficacy Results for ONC201 in Recurrent Glioblastoma Published
05/30/2017 Updated Cheryl`s story - almost 17 year survivor of a gbm!
05/25/2017 HELP US BETTER UNDERSTAND PATIENT EXPERIENCES:
05/25/2017 Study provides better understanding of how brain tumors `feed`


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites